{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/06/24/3316820/29489/en/AIM-ImmunoTech-Accelerates-Toward-Potential-Pivotal-Pancreatic-Cancer-Program-as-Ampligen-Continues-to-Advance-Through-Key-Clinical-Milestones.html", "message": "News view counter 814045 successfully enlarged"}